These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28092671)

  • 1. PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.
    Delyon J; Servy A; Laugier F; André J; Ortonne N; Battistella M; Mourah S; Bensussan A; Lebbé C; Dumaz N
    Oncogene; 2017 Jun; 36(23):3252-3262. PubMed ID: 28092671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.
    Marquette A; André J; Bagot M; Bensussan A; Dumaz N
    Nat Struct Mol Biol; 2011 May; 18(5):584-91. PubMed ID: 21478863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.
    Dumaz N; Hayward R; Martin J; Ogilvie L; Hedley D; Curtin JA; Bastian BC; Springer C; Marais R
    Cancer Res; 2006 Oct; 66(19):9483-91. PubMed ID: 17018604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations.
    Garay T; Molnár E; Juhász É; László V; Barbai T; Dobos J; Schelch K; Pirker C; Grusch M; Berger W; Tímár J; Hegedűs B
    Pathol Oncol Res; 2015 Sep; 21(4):957-68. PubMed ID: 25749811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Kim HS; Jung M; Kang HN; Kim H; Park CW; Kim SM; Shin SJ; Kim SH; Kim SG; Kim EK; Yun MR; Zheng Z; Chung KY; Greenbowe J; Ali SM; Kim TM; Cho BC
    Oncogene; 2017 Jun; 36(23):3334-3345. PubMed ID: 28092667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway.
    Gaggioli C; Robert G; Bertolotto C; Bailet O; Abbe P; Spadafora A; Bahadoran P; Ortonne JP; Baron V; Ballotti R; Tartare-Deckert S
    J Invest Dermatol; 2007 Feb; 127(2):400-10. PubMed ID: 16960555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.
    Kurenova E; Ucar D; Liao J; Yemma M; Gogate P; Bshara W; Sunar U; Seshadri M; Hochwald SN; Cance WG
    Cell Cycle; 2014; 13(16):2542-53. PubMed ID: 25486195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
    Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
    Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference.
    Sumimoto H; Miyagishi M; Miyoshi H; Yamagata S; Shimizu A; Taira K; Kawakami Y
    Oncogene; 2004 Aug; 23(36):6031-9. PubMed ID: 15208655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C; Marais R
    J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts.
    Bruss MD; Richter W; Horner K; Jin SL; Conti M
    J Biol Chem; 2008 Aug; 283(33):22430-42. PubMed ID: 18508768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.
    Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R
    Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on proliferation and melanogenesis by inhibition of mutant BRAF and expression of wild-type INK4A in melanoma cells.
    Rotolo S; Diotti R; Gordon RE; Qiao RF; Yao Z; Phelps RG; Dong J
    Int J Cancer; 2005 May; 115(1):164-9. PubMed ID: 15657897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
    Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
    Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways.
    Mika D; Conti M
    Cell Signal; 2016 Jul; 28(7):719-24. PubMed ID: 26562185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of BRAF(V600E) expression of primary and metastatic melanoma and comparison with mutation status and melanocyte differentiation antigens of metastatic lesions.
    Busam KJ; Hedvat C; Pulitzer M; von Deimling A; Jungbluth AA
    Am J Surg Pathol; 2013 Mar; 37(3):413-20. PubMed ID: 23211290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-RAF: A contributor to the melanoma phenotype.
    Heath EM; Kaufman KL; Christopherson RI
    Int J Biochem Cell Biol; 2011 Jan; 43(1):29-32. PubMed ID: 20883818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A.
    Arozarena I; Sanchez-Laorden B; Packer L; Hidalgo-Carcedo C; Hayward R; Viros A; Sahai E; Marais R
    Cancer Cell; 2011 Jan; 19(1):45-57. PubMed ID: 21215707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.
    Nihal M; Wood GS
    Oncotarget; 2016 Aug; 7(33):53869-53880. PubMed ID: 27472394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.